WallStreetZenWallStreetZen

NASDAQ: NAGE
Niagen Bioscience Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NAGE

Based on 2 analysts offering 12 month price targets for Niagen Bioscience Inc

Min Forecast
$10.00+195.86%
Avg Forecast
$10.50+210.65%
Max Forecast
$11.00+225.44%

Should I buy or sell NAGE stock?

Based on 2 analysts offering ratings for Niagen Bioscience Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NAGE's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NAGE as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their NAGE stock forecasts and price targets.

NAGE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-11
lockedlocked$00.00+00.00%2026-05-05

1 of 1

Forecast return on equity

Is NAGE forecast to generate an efficient return?

Company
41.44%
Industry
30.87%
Market
147.11%
NAGE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NAGE forecast to generate an efficient return on assets?

Company
29.84%
Industry
-1.36%
NAGE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NAGE earnings per share forecast

What is NAGE's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$0.24-1.42%
Avg 2 year Forecast
$0.31+30.71%
Avg 3 year Forecast
$0.43+78.5%
NAGE's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

NAGE revenue forecast

What is NAGE's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$145.1M+11.28%
Avg 2 year Forecast
$170.2M+30.54%
Avg 3 year Forecast
$207.5M+59.08%
NAGE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NAGE earnings growth forecast

How is NAGE forecast to perform vs Biotechnology companies and vs the US market?

Company
16.46%
Industry
23.75%
Market
69.18%
NAGE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NAGE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NAGE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NAGE revenue growth forecast

How is NAGE forecast to perform vs Biotechnology companies and vs the US market?

Company
15.52%
Industry
47.2%
Market
16.15%
NAGE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NAGE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NAGE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NAGE$3.38$10.50+210.65%Strong Buy
EDIT$2.76$6.00+117.39%Strong Buy
IVVD$0.94$10.00+969.52%Strong Buy
ZNTL$3.68$10.00+171.74%Strong Buy
BCYC$4.00$15.60+290.00%Buy
View Top Biotech Stocks

Niagen Bioscience Stock Forecast FAQ

Is Niagen Bioscience Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: NAGE) stock is to Strong Buy NAGE stock.

Out of 2 analysts, 1 (50%) are recommending NAGE as a Strong Buy, 1 (50%) are recommending NAGE as a Buy, 0 (0%) are recommending NAGE as a Hold, 0 (0%) are recommending NAGE as a Sell, and 0 (0%) are recommending NAGE as a Strong Sell.

If you're new to stock investing, here's how to buy Niagen Bioscience stock.

What is NAGE's earnings growth forecast for 2026-2028?

(NASDAQ: NAGE) Niagen Bioscience's forecast annual earnings growth rate of 16.46% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 23.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 69.18%.

Niagen Bioscience's earnings in 2026 is $18,637,000.On average, 7 Wall Street analysts forecast NAGE's earnings for 2026 to be $18,843,848, with the lowest NAGE earnings forecast at $14,049,259, and the highest NAGE earnings forecast at $23,415,432. On average, 6 Wall Street analysts forecast NAGE's earnings for 2027 to be $24,984,425, with the lowest NAGE earnings forecast at $19,512,860, and the highest NAGE earnings forecast at $30,105,556.

In 2028, NAGE is forecast to generate $34,119,630 in earnings, with the lowest earnings forecast at $31,220,576 and the highest earnings forecast at $36,795,679.

What is NAGE's revenue growth forecast for 2026-2028?

(NASDAQ: NAGE) Niagen Bioscience's forecast annual revenue growth rate of 15.52% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 47.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.15%.

Niagen Bioscience's revenue in 2026 is $130,416,000.On average, 7 Wall Street analysts forecast NAGE's revenue for 2026 to be $11,558,781,178, with the lowest NAGE revenue forecast at $10,873,043,522, and the highest NAGE revenue forecast at $12,094,787,498. On average, 6 Wall Street analysts forecast NAGE's revenue for 2027 to be $13,558,650,228, with the lowest NAGE revenue forecast at $12,488,230,474, and the highest NAGE revenue forecast at $14,543,054,110.

In 2028, NAGE is forecast to generate $16,523,808,523 in revenue, with the lowest revenue forecast at $15,306,046,763 and the highest revenue forecast at $17,620,510,905.

What is NAGE's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: NAGE) forecast ROA is 29.84%, which is higher than the forecast US Biotechnology industry average of -1.36%.

What is NAGE's Price Target?

According to 2 Wall Street analysts that have issued a 1 year NAGE price target, the average NAGE price target is $10.50, with the highest NAGE stock price forecast at $11.00 and the lowest NAGE stock price forecast at $10.00.

On average, Wall Street analysts predict that Niagen Bioscience's share price could reach $10.50 by May 11, 2027. The average Niagen Bioscience stock price prediction forecasts a potential upside of 210.65% from the current NAGE share price of $3.38.

What is NAGE's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: NAGE) Niagen Bioscience's current Earnings Per Share (EPS) is $0.24. On average, analysts forecast that NAGE's EPS will be $0.24 for 2026, with the lowest EPS forecast at $0.18, and the highest EPS forecast at $0.29. On average, analysts forecast that NAGE's EPS will be $0.31 for 2027, with the lowest EPS forecast at $0.25, and the highest EPS forecast at $0.38. In 2028, NAGE's EPS is forecast to hit $0.43 (min: $0.39, max: $0.46).

What is NAGE's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: NAGE) forecast ROE is 41.44%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.